STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model

Constitutively activated STAT3 plays an essential role in the initiation, progression, maintenance, malignancy, and drug resistance of cancer, including glioblastoma, suggesting that STAT3 is a potential therapeutic target for cancer therapy. We recently identified ODZ10117 as a small molecule inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byung-Hak, Lee, Haeri, Park, Cheol Gyu, Jeong, Ae Jin, Lee, Song-Hee, Noh, Kum Hee, Park, Jong Bae, Lee, Chung-Gi, Paek, Sun Ha, Kim, Hyunggee, Ye, Sang-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140655/
https://www.ncbi.nlm.nih.gov/pubmed/32183406
http://dx.doi.org/10.3390/cells9030722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140655/
https://www.ncbi.nlm.nih.gov/pubmed/32183406
http://dx.doi.org/10.3390/cells9030722

Ejemplares similares